RECTAL ABSORPTION OF MORPHINE FROM CONTROLLED-RELEASE SUPPOSITORIES

被引：8
|
作者：
MOOLENAAR, F
MEYLER, P
FRIJLINK, E
JAUW, TH
VISSER, J
PROOST, H
机构：
[1] PHARM ZEEBURG,1019 AT AMSTERDAM,NETHERLANDS
[2] PIJNWERKGRP AZG,9713 EZ GRONINGEN,NETHERLANDS
来源：
INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1995年 / 114卷 / 01期
关键词：
MORPHINE; RECTAL ABSORPTION; CONTROLLED RELEASE; MS CONTIN;
D O I：
10.1016/0378-5173(94)00219-U
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The absorption profiles and bioavailability of morphine in human volunteers (n = 13) were described after oral administration of MS Contin tablets and rectal administration of a newly developed controlled release suppository. By manipulating the viscosity of fatty suppository base an entirely identical cumulative morphine input could be obtained compared with oral dosing.
引用
收藏
页码：117 / 120
页数：4
相关论文
共 50 条
  • [1] Design of controlled-release morphine suppositories containing polyglycerol ester of fatty acid
    Takatori, T
    Yamamoto, K
    Yamaguchi, T
    Higaki, K
    Kimura, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (08) : 1480 - 1484
  • [2] Comparative efficacy and safety of controlled-release morphine suppositories and tablets in cancer pain
    Babul, N
    Provencher, L
    Laberge, F
    Harsanyi, Z
    Moulin, D
    JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (01): : 74 - 81
  • [3] EFFICACY, SAFETY AND PHARMACOKINETICS OF CONTROLLED-RELEASE MORPHINE SUPPOSITORIES AND TABLETS IN CANCER PAIN
    DARKE, A
    MOULIN, D
    PROVENCHER, L
    LABERGE, F
    HARSANYI, Z
    BABUL, N
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 165 - 165
  • [4] A GAMMA SCINTIGRAPHIC STUDY OF THE ABSORPTION OF MORPHINE FROM CONTROLLED-RELEASE TABLETS
    OLSSON, B
    WAGNER, ZG
    MANSSON, P
    RAGNARSSON, G
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 119 (02) : 223 - 229
  • [5] PHARMACOKINETICS OF 2 NOVEL RECTAL CONTROLLED-RELEASE MORPHINE FORMULATIONS
    BABUL, N
    DARKE, AC
    ANSLOW, JA
    KRISHNAMURTHY, TN
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (07) : 400 - 405
  • [6] RELEASE AND RECTAL ABSORPTION OF ETHOSUXIMIDE FROM SUPPOSITORIES IN RABBITS
    GHAZY, FS
    MOHAMED, MS
    KASSEM, AA
    ELHOSEINY, BM
    JOURNAL DE PHARMACIE DE BELGIQUE, 1988, 43 (06) : 425 - 428
  • [7] RELEASE AND RECTAL ABSORPTION OF ETHOSUXIMIDE FROM SUPPOSITORIES IN RABBITS
    GHAZY, FS
    MOHAMED, MS
    KASSEM, AA
    ELHOSEINY, BM
    PHARMAZIE, 1988, 43 (07): : 484 - 485
  • [8] CROSSOVER BIOAVAILABILITY COMPARISON OF ORAL AND RECTAL CONTROLLED-RELEASE MORPHINE FORMULATIONS
    BABUL, N
    DARKE, AC
    ANSLOW, JA
    KRISHNAMURTHY, TN
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 148 - 148
  • [9] CONTROLLED-RELEASE MORPHINE TABLETS
    HANKS, GW
    ROSE, NM
    AHERNE, GW
    PIALL, EM
    FAIRFIELD, S
    TRUEMAN, T
    BRITISH JOURNAL OF ANAESTHESIA, 1981, 53 (12) : 1259 - 1264
  • [10] THE BIOAVAILABILITY OF MORPHINE IN CONTROLLED-RELEASE 30-MG TABLETS PER RECTUM COMPARED WITH IMMEDIATE-RELEASE 30-MG RECTAL SUPPOSITORIES AND CONTROLLED-RELEASE 30-MG ORAL TABLETS
    KAIKO, RF
    FITZMARTIN, RD
    THOMAS, GB
    GOLDENHEIM, PD
    PHARMACOTHERAPY, 1992, 12 (02): : 107 - 113
12345